Singapore, Oct. 7 -- Japan-based medtech company Olympus Corporation has announced the launch of SecureFlex, a single-use fine needle biopsy device. SecureFlex will be commercially available in Europe and Japan in Autumn 2025, with a subsequent global rollout subject to regulatory requirements such as product registration and market clearance.

Designed for use with an ultrasound endoscope, SecureFlex supports endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) of submucosal and extramural lesions within the gastrointestinal tract. Its primary clinical application is in the diagnosis of diseases such as pancreatic cancer.

EUS-FNB is an examination technique that combines ultrasound and endoscopy technologies, enabling physicians to...